Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Chimeric antigen and T cell receptors and methods of use

Grant US-11793834-B2

United States of America

Chimeric antigen receptors and CAR-T cells and methods of use

Grant AU-2019397033-B2

Australia

Chimeric antigens and T cell receptors and methods of use

Application CN-113412117-A

China

CHIMERIC ANTIGEN RECEPTORS AND CAR-T CELLS AND METHODS OF USE

Application WO-2020123691-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.